Hedge Fund - Deerfield Management
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $167,975,651 | 2.15% | 1,184,345 | $144.87 |
| 2 | 2025 - Q3 (2025-09-30) | $166,258,351 | 2.54% | 1,184,345 | $135.50 |
| 3 | 2025 - Q2 (2025-06-30) | $146,781,033 | 2.66% | 1,167,802 | $114.68 |
| 4 | 2025 - Q1 (2025-03-31) | $164,683,400 | 3.25% | 1,489,000 | $126.68 |
| 5 | 2024 - Q4 (2024-12-31) | $117,663,000 | 2.22% | 862,000 | $123.68 |
| 6 | 2024 - Q3 (2024-09-30) | $151,697,500 | 2.26% | 1,316,590 | $137.09 |
| 7 | 2024 - Q2 (2024-06-30) | $95,130,521 | 1.58% | 691,004 | $137.14 |
| 8 | 2024 - Q1 (2024-03-31) | $95,303,272 | 1.65% | 691,004 | $136.57 |
| 9 | 2023 - Q4 (2023-12-31) | $118,151,695 | 2.18% | 896,719 | $115.11 |
| 10 | 2023 - Q3 (2023-09-30) | $136,092,825 | 2.99% | 1,209,714 | $105.30 |
| 11 | 2023 - Q2 (2023-06-30) | $114,076,030 | 2.43% | 1,209,714 | $97.71 |
| 12 | 2023 - Q1 (2023-03-31) | $176,599,951 | 3.93% | 1,744,714 | $104.06 |
| 13 | 2022 - Q4 (2022-12-31) | $180,678,560 | 3.73% | 1,512,714 | $117.13 |
| 14 | 2022 - Q3 (2022-09-30) | $160,665,000 | 3.19% | 1,512,714 | $101.46 |
| 15 | 2022 - Q2 (2022-06-30) | $196,199,000 | 4.04% | 2,012,714 | $92.29 |
| 16 | 2022 - Q1 (2022-03-31) | $155,419,000 | 3.47% | 1,657,800 | $84.75 |
| 17 | 2021 - Q4 (2021-12-31) | $117,360,000 | 2.46% | 1,377,945 | $91.99 |
| 18 | 2021 - Q3 (2021-09-30) | $109,569,000 | 2.13% | 1,142,415 | $94.46 |
| 19 | 2021 - Q2 (2021-06-30) | $70,557,000 | 1.25% | 725,000 | $95.85 |
| 20 | 2021 - Q1 (2021-03-31) | $70,506,000 | 1.48% | 725,000 | $104.86 |
| 21 | 2014 - Q3 (2014-09-30) | $0 | 0% | 0 | $14.95 |
| 22 | 2014 - Q2 (2014-06-30) | $788,000 | 0.03% | 53,094 | $14.11 |
| 23 | 2014 - Q1 (2014-03-31) | $1,256,000 | 0.05% | 77,994 | $17.10 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center